购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-53(Compound 88)作为一种羟基类固醇17β-脱氢酶13 (HSD17B13) 的抑制剂,展示了对雌二醇的高效抑制作用,其IC50值达到或低于0.1 μM。此化合物主要应用于研究肝病、代谢性及心血管疾病,特别是NAFLD、NASH及药物性肝损伤(DILI)等病症。
HSD17B13-IN-53(Compound 88)作为一种羟基类固醇17β-脱氢酶13 (HSD17B13) 的抑制剂,展示了对雌二醇的高效抑制作用,其IC50值达到或低于0.1 μM。此化合物主要应用于研究肝病、代谢性及心血管疾病,特别是NAFLD、NASH及药物性肝损伤(DILI)等病症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-53 (Compound 88) serves as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), demonstrating an IC 50 of ≤ 0.1 μM against estradiol. This compound is utilized in the study of liver, metabolic, and cardiovascular diseases, including NAFLD and NASH, besides its application in drug-induced liver injury (DILI) [1]. |
分子量 | 538.3 |
分子式 | C24H16Cl2F3N3O4 |
CAS No. | 2770246-81-4 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容